Authors:
Brown, K
Guenther, EA
Dingley, KH
Cosman, M
Harvey, CA
Shields, SJ
Turteltaub, KW
Citation: K. Brown et al., Synthesis and spectroscopic characterization of site-specific 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine oligodeoxyribonucleotide adducts, NUCL ACID R, 29(9), 2001, pp. 1951-1959
Authors:
Brown, K
Hingerty, BE
Guenther, EA
Krishnan, VV
Broyde, S
Turteltaub, KW
Cosman, M
Citation: K. Brown et al., Solution structure of the 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine C8-deoxyguanosine adduct in duplex DNA, P NAS US, 98(15), 2001, pp. 8507-8512
Citation: Kw. Turteltaub et Js. Vogel, Bioanalytical applications of accelerator mass spectrometry for pharmaceutical research, CUR PHARM D, 6(10), 2000, pp. 991-1007
Authors:
Phillips, DH
Farmer, PB
Beland, FA
Nath, RG
Poirier, MC
Reddy, MV
Turteltaub, KW
Citation: Dh. Phillips et al., Methods of DNA adduct determination and their application to testing compounds for genotoxicity, ENV MOL MUT, 35(3), 2000, pp. 222-233
Authors:
Goldman, R
Day, BW
Carver, TA
Mauthe, RJ
Turteltaub, KW
Shields, PG
Citation: R. Goldman et al., Quantitation of benzo[a]pyrene-DNA adducts by postlabeling with C-14-acetic anhydride and accelerator mass spectrometry, CHEM-BIO IN, 126(3), 2000, pp. 171-183
Citation: Kh. Dingley et al., DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, CANC EPID B, 8(6), 1999, pp. 507-512
Authors:
Lang, NP
Nowell, S
Malfatti, MA
Kulp, KS
Knize, MG
Davis, C
Massengill, J
Williams, S
MacLeod, S
Dingley, KH
Felton, JS
Turteltaub, KW
Citation: Np. Lang et al., In vivo human metabolism of [2-C-14]2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP), CANCER LETT, 143(2), 1999, pp. 135-138
Citation: Kw. Turteltaub et al., Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses, CANCER LETT, 143(2), 1999, pp. 149-155
Authors:
Garner, RC
Lightfoot, TJ
Cupid, BC
Russell, D
Coxhead, JM
Kutschera, W
Priller, A
Rom, W
Steier, P
Alexander, DJ
Leveson, SH
Dingley, KH
Mauthe, RJ
Turteltaub, KW
Citation: Rc. Garner et al., Comparative biotransformation studies of MeIQx and PhIP in animal models and humans, CANCER LETT, 143(2), 1999, pp. 161-165
Authors:
Malfatti, MA
Kulp, KS
Knize, MG
Davis, C
Massengill, JP
Williams, S
Nowell, S
MacLeod, S
Dingley, KH
Turteltaub, KW
Lang, NP
Felton, JS
Citation: Ma. Malfatti et al., The identification of [2-C-14]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans, CARCINOGENE, 20(4), 1999, pp. 705-713
Authors:
Mani, C
Freeman, S
Nelson, DO
Vogel, JS
Turteltaub, KW
Citation: C. Mani et al., Species and strain comparisons in the macromolecular binding of extremely low doses of [C-14]benzene in rodents, using accelerator mass spectrometry, TOX APPL PH, 159(2), 1999, pp. 83-90
Authors:
Kwok, ESC
Buchholz, BA
Vogel, JS
Turteltaub, KW
Eastmond, DA
Citation: Esc. Kwok et al., Dose-dependent binding of ortho-phenylphenol to protein but not DNA in theurinary bladder of male F344 rats, TOX APPL PH, 159(1), 1999, pp. 18-24
Citation: Rj. Mauthe et al., Comparison of DNA-adduct and tissue-available dose levels of MeIQx in human and rodent colon following administration of a very low dose, INT J CANC, 80(4), 1999, pp. 539-545
Citation: Kw. Turteltaub et Kh. Dingley, Application of accelerated mass spectrometry (AMS) in DNA adduct quantification and identification, TOX LETT, 103, 1998, pp. 435-439